Yen Kristen 的 Form 4 申報
Soleno Therapeutics IncSLNO，2025/3/31 申報
- 申報編號
- 0001415889-25-009297
- 申報時間
- 2025/3/31
- 交易日
- 2025/3/27
- 申報延遲
- 4 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 13 筆非衍生性交易、3 筆衍生性交易。公開市場賣出合計 $637.7 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Yen KristenCIK 0001643441 | 高階主管（見申報備註） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/3/27 | Common Stock | S賣出處分 | −1,769 | $65.97F2 | −$116,700.93 | 81,236 | 直接 | |
| 2025/3/27 | Common Stock | S賣出處分 | −2,881 | $66.79F4 | −$192,421.99 | 78,355 | 直接 | |
| 2025/3/27 | Common Stock | S賣出處分 | −5,239 | $67.70F5 | −$354,680.3 | 73,116 | 直接 | |
| 2025/3/27 | Common Stock | S賣出處分 | −6,891 | $68.79F6 | −$474,031.89 | 66,225 | 直接 | |
| 2025/3/27 | Common Stock | S賣出處分 | −3,990 | $69.84F7 | −$278,661.6 | 62,235 | 直接 | |
| 2025/3/27 | Common Stock | S賣出處分 | −411 | $70.73F8 | −$29,070.03 | 61,824 | 直接 | |
| 2025/3/27 | Common Stock | S賣出處分 | −597 | $71.74F9 | −$42,828.78 | 61,227 | 直接 | |
| 2025/3/27 | Common Stock | S賣出處分 | −91 | $72.64F10 | −$6,610.24 | 61,136 | 直接 | |
| 2025/3/27 | Common Stock | M行使選擇權取得 | +4,888 | $5.10 | +$24,928.8 | 66,024 | 直接 | |
| 2025/3/27 | Common Stock | M行使選擇權取得 | +3,750 | $2.41 | +$9,037.5 | 69,774 | 直接 | |
| 2025/3/27 | Common Stock | M行使選擇權取得 | +32,000 | $5.25 | +$168,000 | 101,774 | 直接 | |
| 2025/3/27 | Common Stock | S賣出處分 | −50,156 | $66.00F11 | −$3,310,296 | 51,618 | 直接 | |
| 2025/3/27 | Common Stock | S賣出處分 | −23,475 | $66.95F12 | −$1,571,651.25 | 28,143 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/3/27 | Common Stock | M行使選擇權處分 | −4,888 | $0.00 | $0 | 2,445 | 直接 | |
| 2025/3/27 | Common Stock | M行使選擇權處分 | −3,750 | $0.00 | $0 | 11,667 | 直接 | |
| 2025/3/27 | Common Stock | M行使選擇權處分 | −32,000 | $0.00 | $0 | 55,392 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
This transaction was executed in multiple trades at prices ranging from $65.15 to $66.145. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $66.24 to $67.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
This transaction was executed in multiple trades at prices ranging from $67.24 to $68.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
This transaction was executed in multiple trades at prices ranging from $68.24 to $69.225. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F7
This transaction was executed in multiple trades at prices ranging from $69.24 to $70.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F8
This transaction was executed in multiple trades at prices ranging from $70.24 to $71.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F9
This transaction was executed in multiple trades at prices ranging from $71.26 to $72.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F10
This transaction was executed in multiple trades at prices ranging from $72.31 to $72.80. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F11
This transaction was executed in multiple trades at prices ranging from $65.74 to $66.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F12
This transaction was executed in multiple trades at prices ranging from $66.75 to $67.10. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
備註
Officer title: SVP Global Clinical Operations and Patient Advocacy